This seminal paper systematically assessed the therapeutic potential of key enzymes—IDO1, IDO2, TDO, and KMO (Kynurenine 3-monooxygenase)—highlighting their roles in immune modulation and tumor immune evasion. The gene discussed is TDO2; the disease is neoplasm.